Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: Role of cytochrome P450 2E1 and 2A5

Hepatology

Volumn 44, Issue 1, 2006, Pages 263-274

  Lu, Yongke ^a   Cederbaum, Arthur I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CLOMETHIAZOLE; CYTOCHROME P450 2A1; CYTOCHROME P450 2E1; LIPOPOLYSACCHARIDE; PYRAZOLE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; KNOCKOUT MOUSE; LIVER INJURY; MALE; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; WILD TYPE;

ALCOHOL DEHYDROGENASE; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CYTOCHROME P-450 CYP2E1; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG SYNERGISM; ENZYME INHIBITORS; IN SITU NICK-END LABELING; LIPOPOLYSACCHARIDES; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; PYRAZOLES; SEVERITY OF ILLNESS INDEX; STEROID HYDROXYLASES;

EID: 33745927724     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21241     Document Type: Article

References (45)

1. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003;124:778-790.
2. Kessoval, Cederbaum AI. CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr Mol Med 2003;3:509-518.
3. Cederbaum AI. Introduction-serial review: Alcohol, oxidative stress, and cell injury. Free Radic Biol Med 2001;31:1524-1526.
4. Zima T, Albano E, Ingelman-Sundberg M, Arteel GE, Thiele GM, Klassen LW, et al. Modulation of oxidative stress by alcohol. Alcohol Clin Exp Res 2005;29:1060-1065.
5. Rao RK, Sedi A, Sheth P. Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004;286:G881-G884.
6. Enomoto N, Takei Y, Hirose M, Ikejima K, Miwa H, Kitamura T, et al. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production. Gastroenterology 2002;123:291-300.
7. Hewett JA, Jean PA, Kunkel SL, Roth RA. Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury. Am J Physiol 1993;265:G1011-G1015.
8. Suzuki S, Nakamura S, Serizawa A, Sakaguchi T, Konno H, Muro H, et al. Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomy. HEPATOLOGY 1996;24:219-225.
9. Wang JH, Redmond HP, Watson RW, Bouchier-Hayes D. Role of lipopolysaccharide and tumor necrosis factor-alpha in induction of hepatocyte necrosis. Am J Physiol 1995;269:G297-G304.
10. Lu Y, Wang X, Cederbaum AI. Lipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazole. Am J Physiol Gastrointest Liver Physiol 2005;289:G308-G319.
11. Feytmans E, Morales MN, Leighton F. Effect of pyrazole on rat liver catalase. Biochem Pharmacol 1974;23:1293-1305.
12. Wang X, Lu Y, Cederbaum AI. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice. HEPATOLOGY 2005;42:400-410.
13. Juvonen RO, Kaipainen PK, Lang MA. Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice. Eur J Biochem 1985;152:3-8.
14. Gilmore WJ, Hartmann G, Piquette-Miller M, Marriott J, Kirby GM. Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression. Toxicology 2003;184:211-226.
15. Hu Y, Mishin V, Johansson I, von Bahr C, Cross A, Ronis MJ, et al. Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver. J Pharmacol Exp Ther 1994;269:1286-1291.
16. Gouillon Z, Lucas D, Li J, Hagbjork AL, French BA, Fu P, et al. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proc Soc Exp Biol Med 2000;224:302-318.
17. Lee HC, Jung SA, Jung HK, Yi SY, Kim DY, Moon IH, et al. Protective effect of chlormethiazole, a sedative, against acetaminophen-induced liver injury in mice. Korean J Intern Med 1999;14:27-33.
18. Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 1996;271: 12063-12067.
19. Wong FW, Chan WY, Lee SS. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol Appl Pharmacol 1998;153:109-118.
20. Constan AA, Sprankle CS, Peters JM, Kedderis GL, Everitt JI, Wong BA, et al. Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicol Appl Pharmacol 1999;160:120-126.
21. Kono H, Bradford BU, Yin M, Sulik KK, Koop DR, Peters JM, et al. CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol 1999;277:G1259-G1267.
22. Funae Y, Imaoka S. Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochim Biophys Acta 198;842:119-132.
23. Reinke LA, Moyer MJ. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab Dispos 1985;13: 548-552.
24. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-126.
25. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998;356:1-11.
26. Yang MX, Cederbaum AI. Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells. Biochem Biophys Res Commun 1996;226:711-716.
27. Wu DF, Clejan L, Potter B, Cederbaum AI. Rapid decrease of cytochrome P-450HE1 in primary hepatocyte culture and its maintenance by added 4-methylpyrazole. HEPATOLOGY 1990;12:1379-1389.
28. Cheng PY, Wang M, Morgan ET. Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin. J Pharmacol Exp Ther 2003;307:1205-1212.
29. Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A 1979; 76:5939-5943.
30. Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A, Jones DA. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998;160:3480-3486.
31. Takemura S, Minamiyama Y, Imaoka S, Funae Y, Hirohashi K, Inoue M, et al. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J Hepatol 1999;30:1035-1044.
32. Minamiyama Y, Takemura S, Toyokuni S, Imaoka S, Funae Y, Hirohashi K, et al. CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats. Free Radic Biol Med 2004;37: 703-712.
33. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992;6:724-730.
34. Lieber CS. Cytochrome P450 2E1: its physiological and pathological role. Physiol Rev 1997;77:517-544.
35. Bolt HM, Roos PH, Their R. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 2003;76:174-185.
36. Tanaka E, Terada M, Misawa S. Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 2000;25:165-175.
37. Yang CS, Yoo JS, Ishizaki H, Hong JY. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 1990;22:147-159.
38. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989;38: 1313-1319.
39. Boveris A, Fraga CG, Varsavsky Al, Koch OR. Increased chemiluminescence and superoxide production in the liver of chronically ethanol-treated rats. Arch Biochem Biophys 1983;227:534-541.
40. Rashba-Step J, Turro NJ, Cederbaum AI. Increased NADPH- and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Arch Biochem Biophys 1993; 300:401-408.
41. Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 2003;44:27-42.
42. Lu Y, Cederbaum AI. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol Sci 2006;89: 515-523.
43. Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001;31:1544-1549.
44. Zhuo X, Gu J, Behr MJ, Swiatek PJ, Cui H, Zhang QY, et al. Targeted disruption of the olfactory mucosa-specific Cyp2g1 gene: impact on acetaminophen toxicity in the lateral nasal gland, and tissue-selective effects on Cyp2a5 expression. J Pharmacol Exp Ther 2004;308:719-728.
45. Raunio H, Syngelma T, Pasanen M, Juvonen R, Honkakoski P, Kairaluoma MA, et al. Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem Pharmacol 1988;37:3889-3895.